Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Asian Sildenafil Efficacy and Safety Study (ASSESS-1): A double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction
Autore:
Tan, HM; Moh, CLC; Mendoza, JB; Gana, T; Albano, GJ; de la Cruz, R; Chye, PLH; Sam, CCW;
Indirizzi:
Subang Jaya Med Ctr, Selangor 47500, Malaysia Subang Jaya Med Ctr Selangor Malaysia 47500 tr, Selangor 47500, Malaysia St Lukes Med Ctr, Quezon, Philippines St Lukes Med Ctr Quezon Philippines Lukes Med Ctr, Quezon, Philippines Univ Malaysia Sarawak, Sarawak, Malaysia Univ Malaysia Sarawak Sarawak Malaysia aysia Sarawak, Sarawak, Malaysia Manila Doctors Hosp, Manila, Philippines Manila Doctors Hosp Manila Philippines octors Hosp, Manila, Philippines Santa Tomas Univ Hosp, Manila, Philippines Santa Tomas Univ Hosp Manila Philippines Univ Hosp, Manila, Philippines Cardinal Santos Med Ctr, Metro Manila, Philippines Cardinal Santos Med Ctr Metro Manila Philippines ro Manila, Philippines New Changi Hosp, Singapore, Singapore New Changi Hosp Singapore Singapore w Changi Hosp, Singapore, Singapore Singapore Gen Hosp, Singapore 0316, Singapore Singapore Gen Hosp Singapore Singapore 0316 p, Singapore 0316, Singapore
Titolo Testata:
UROLOGY
fascicolo: 4, volume: 56, anno: 2000,
pagine: 635 - 640
SICI:
0090-4295(200010)56:4<635:ASEASS>2.0.ZU;2-8
Fonte:
ISI
Lingua:
ENG
Soggetto:
PSYCHOGENIC IMPOTENCE; TRAZODONE; YOHIMBINE; TRIAL;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
17
Recensione:
Indirizzi per estratti:
Indirizzo: Tan, HM Subang Jaya Med Ctr, 1 Jalan SS 12-1A, Selangor 47500, Malaysia Subang Jaya Med Ctr 1 Jalan SS 12-1A Selangor Malaysia 47500 ysia
Citazione:
H.M. Tan et al., "Asian Sildenafil Efficacy and Safety Study (ASSESS-1): A double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction", UROLOGY, 56(4), 2000, pp. 635-640

Abstract

Objectives. To evaluate the efficacy, safety, and tolerability of oral sildenafil in Asian men with erectile dysfunction of various causes (organic, psychogenic, or mixed) and of more than 6 months' duration. Methods. In this double-blind, parallel-group trial conducted at eight centers in Malaysia, the Philippines, and Singapore, 254 men, 26 to 78 years old, were randomized to 12 weeks of sildenafil or placebo taken as needed I hour before anticipated sexual activity. initially, the sildenafil (n = 127) or matching placebo tn = 127) dose was 50 mg but could be increased to 100 mg or decreased to 25 mg because of a lack of efficacy or intolerance, respectively, Efficacy was assessed by the 15-question international Index ofErectile Function, patients' event logs of sexual activity, and a global efficacy question about erections. Results. The two primary efficacy variables relating to achievement and maintenance of an erection sufficient for sexual intercourse, as assessed by the mean scores for International Index of Erectile Function question 3 (4.22 versus 2.59) and question 4 (4.15 versus 2.41), were both significantly higher with sildenafil than with placebo (P <0.0001). in addition, the fiveseparate international index of Erectile Function domains of sexual function, the percentage of successful intercourse attempts, and the global efficacy assessment of erections revealed significantly greater treatment effects in favor of sildenafil [P <0.0001 versus placebo for all variables). Treatment-related adverse events occurred in 22.8% of patients who received sildenafil and in 10.2% of those who received placebo. Conclusions. Sildenafil is an effective and well-tolerated treatment for Asian men with erectile dysfunction of broad-spectrum etiology. UROLOGY 56: 635-640, 2000. (C) 2000, Elsevier Science Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/20 alle ore 07:27:26